The Current Research of Mikhail Blagosklonny

Mikhail Blagosklonny is considered to be one of the most influential individuals within the field of medicine due to not only his perseverance, but also due to the interesting research topics that he has pursued within the field of medicine that have interested many other individuals for future studies that will help others around the world. Mikhail Blagosklonny is specifically interested with the study of cancer mixed with the study of aging. Mikhail Blagosklonny is interested in researching not only the mechanism for aging, but also how it is connected with cancerous cells. Mikhail Blagosklonny hopes to one day discover a way to treat cancerous cells without hurting the patient and preventing full recovery for the future through the processes of radiation as well as chemotherapy. Mikhail Blagosklonny is passionate within the field of study and hopes that it will truly make a difference for cancer patients who suffer constantly around the world.

Mikhail Blagosklonny has the goal of developing a cancer treatment that will target cancerous cells within the body without damaging the normal cells. Mikhail Blagosklonny wants to not only prevent cancer, but also prevent cancer in a more comfortable and effective manner on impactjournals.com. With the constant progress that is being made within the field of oncology, Mikhail Blagosklonny sees this as a possible goal. In addition to the study of oncology, Mikhail Blagosklonny has also done much research that concerns that process of aging. Despite the loftiness of the goal, Mikhail Blagosklonny has been fascinated with creating an anti-aging drug that could also prevent many health defects that are common at old age. Source: https://www.linkedin.com/in/mikhail-blagosklonny-91abb531

Mikhail Blagosklonny loves teaching and is especially excited to inspire not only his peers, but also his students with the study of oncology on Impactjournals.com. For future plans, Mikhail Blagosklonny will continue to teach at prestigious institutes and will continue his research on both oncology as well as on aging in the hopes that his research will be continued in the future.